跳至主要内容
临床试验/DRKS00021214
DRKS00021214已完成未知

Improvement of the nutritional status regarding nicotinamide (vitamin B3) and the course of COVID-19 disease - COVit

Klinik für Innere Medizin I (UKSH Campus Kiel)0 个研究点目标入组 900 人开始时间: 2020年4月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
900

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • SARS-CoV-2 infection confirmed by laboratory findings; the positive test must not date back more than 7 days.
  • Relevant infection symptoms, e.g. in the respiratory or gastrointestinal tract.
  • The patient has been able to give written consent via a website before any trial procedure is performed and can comply with the trial-dependent prerequisites and requirements.

排除标准

  • Current participation in another trial.
  • Pregnancy or breastfeeding.
  • Vaccination against SARS-CoV-2.

研究者

发起方
Klinik für Innere Medizin I (UKSH Campus Kiel)

相似试验